Dr. Hahn has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from UCB and Abbott, and has served on the Data and Safety Monitoring Board for Anthera.
American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis†
Article first published online: 3 MAY 2012
Copyright © 2012 by the American College of Rheumatology
Arthritis Care & Research
Volume 64, Issue 6, pages 797–808, June 2012
How to Cite
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., Ramsey-Goldman, R., Singh, K., Khalighi, M., Choi, S.-I., Gogia, M., Kafaja, S., Kamgar, M., Lau, C., Martin, W. J., Parikh, S., Peng, J., Rastogi, A., Chen, W. and Grossman, J. M. (2012), American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res, 64: 797–808. doi: 10.1002/acr.21664
Members of the Task Force Panel: Jo H. M. Berden, Jill P. Buyon, Gabriel Contreras, Karen H. Costenbader, Mary Anne Dooley, Peng Thim Fan, Rosalind Ramsey-Goldman, Frederic A. Houssiau, David A. Isenberg, Kenneth C. Kalunian, Susan Manzi, Chi-Chiu Mok, Liz Shaw-Stabler, Brad Rovin, Murray B. Urowitz, and David Wofsy.
- Issue published online: 3 MAY 2012
- Article first published online: 3 MAY 2012
- Manuscript Accepted: 5 MAR 2012
- Manuscript Received: 15 JUN 2011